Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: Results from the SIMONE study
Giuseppe Vittorio De Socio(University of Perugia), Paolo Bonfanti(University of California San Diego), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio), Claudio Sfara, Giuseppe Schillaci(State University of New York), Beatrice Adriani(Hospital of Prato), Francesca Vichi, Elena Ricci(Mario Negri Institute for Pharmacological Research), Canio Martinelli(Azienda Ospedaliero-Universitaria Careggi), Giustino Parruti(Azienda USL di Pescara), Giordano Madeddu(University of Sassari), Marzia Franzetti, Giovanni Penco(Ente Ospedaliero Ospedali Galliera), Patrizia Marconi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)
Cited by 56
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension
|Hypertension|2005|318